These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12171279)

  • 1. Motivational interviewing to improve insight and treatment adherence in schizophrenia.
    Rüsch N; Corrigan PW
    Psychiatr Rehabil J; 2002; 26(1):23-32. PubMed ID: 12171279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight development in schizophrenia: the construction of dangerousness in relapse.
    Nordick WG; van Heugten K
    Qual Health Res; 2014 May; 24(5):591-602. PubMed ID: 24699905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insight into illness and compliance in schizophrenic disorders].
    Zsolt JL; György B
    Psychiatr Hung; 2006; 21(6):413-21. PubMed ID: 17438658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight in schizophrenia: a review.
    Baier M
    Curr Psychiatry Rep; 2010 Aug; 12(4):356-61. PubMed ID: 20526897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of self-complexity in reducing harmful insight among persons with schizophrenia. Theoretical and therapeutic implications.
    Martens WH
    Am J Psychother; 2009; 63(1):53-68. PubMed ID: 19425334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lack of insight in schizophrenia: a review. Part I: theoretical concept, clinical aspects and Amador's model].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Dec; 34(6):597-605. PubMed ID: 19081457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological underpinnings of insight deficits in schizophrenia.
    Shad MU; Keshavan MS; Tamminga CA; Cullum CM; David A
    Int Rev Psychiatry; 2007 Aug; 19(4):437-46. PubMed ID: 17671876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lack of insight in schizophrenia: a review].
    Raffard S; Bayard S; Capdevielle D; Garcia F; Boulenger JP; Gely-Nargeot MC
    Encephale; 2008 Oct; 34(5):511-6. PubMed ID: 19068341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insight into illness: an overview of the concept focusing on schizophrenia].
    Bottlender R; Hloucal TM
    Psychiatr Prax; 2010 Mar; 37(2):59-67. PubMed ID: 19724996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of neurocognitive deficits and unawareness of illness in schizophrenia.
    Lysaker PH; Lancaster RS; Davis LW; Clements CA
    J Nerv Ment Dis; 2003 Jan; 191(1):38-44. PubMed ID: 12544598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of insight in schizophrenia: impact on treatment adherence.
    Buckley PF; Wirshing DA; Bhushan P; Pierre JM; Resnick SA; Wirshing WC
    CNS Drugs; 2007; 21(2):129-41. PubMed ID: 17284095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of motivational interviews on treatment adherence and insight levels of patients with schizophrenia: A randomized controlled study.
    Ertem MY; Duman ZÇ
    Perspect Psychiatr Care; 2019 Jan; 55(1):75-86. PubMed ID: 29888541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Motivational Interviewing on Medication Adherence in Schizophrenia.
    Vanderwaal FM
    Issues Ment Health Nurs; 2015; 36(11):900-4. PubMed ID: 26631862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivational interviewing: addressing ambivalence to improve medication adherence in patients with bipolar disorder.
    Laakso LJ
    Issues Ment Health Nurs; 2012 Jan; 33(1):8-14. PubMed ID: 22224961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of motivational interviewing-based adherence therapy for schizophrenia spectrum disorders: a randomized controlled trial.
    Chien WT; Mui JH; Cheung EF; Gray R
    Trials; 2015 Jun; 16():270. PubMed ID: 26072311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication adherence in patients with schizophrenia: a qualitative study of the patient process in motivational interviewing.
    Dobber J; Latour C; de Haan L; Scholte Op Reimer W; Peters R; Barkhof E; van Meijel B
    BMC Psychiatry; 2018 May; 18(1):135. PubMed ID: 29776393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].
    Bechdolf A; Pohlmann B; Geyer C; Ferber C; Klosterkötter J; Gouzoulis-Mayfrank E
    Fortschr Neurol Psychiatr; 2005 Dec; 73(12):728-35. PubMed ID: 16355315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.